Antioxidant activity of erlotinib and gefitinib: theoretical and experimental insights
Sign Up to like & getrecommendations! Published in 2022 at "Free Radical Research"
DOI: 10.1080/10715762.2022.2065990
Abstract: Abstract Erlotinib and gefitinib are quinazoline derivatives with antineoplastic properties. Usually, intake of antineoplastic agents results in much a greater degree of oxidative stress, i.e. the production of free radicals, than induced by cancer itself.… read more here.
Keywords: activity erlotinib; transfer; antioxidant activity; erlotinib gefitinib ... See more keywords
Shikonin sensitizes wild-type EGFR NSCLC cells to erlotinib and gefitinib therapy
Sign Up to like & getrecommendations! Published in 2018 at "Molecular Medicine Reports"
DOI: 10.3892/mmr.2018.9347
Abstract: As patients with non-small cell lung cancer (NSCLC) and wild-type epidermal growth factor receptor (EGFR) are resistant to treatment with erlotinib or gefitinib, potential chemosensitizers are required to potentiate wild-type EGFR NSCLC cells to erlotinib/gefitinib… read more here.
Keywords: type egfr; erlotinib gefitinib; egfr nsclc; wild type ... See more keywords